Skip to main content
. 2014 Aug 26;3(4):e001090. doi: 10.1161/JAHA.114.001090

Table 6.

Pre‐ and In‐Hospital Characteristics Among Patients With ST‐Segment Elevation Myocardial Infarction

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 P Value
N (sample) 64 918 316 871 59 433 54 960 46 332 41 405 43 559 37 249 37 556 34 200 32 900
N (weighted) 316 871 10 744 286 615 262 937 225 706 202 291 211 620 184 115 184 442 172 006 164 297
Prehospital
Sex, %
Male 63.23 63.76 64.03 64.72 65.02 65.50 66.95 66.85 67.17 68.39 68.74 <0.0001
Female 36.77 36.24 35.97 35.28 34.98 34.50 33.06 33.15 32.83 31.61 31.26 <0.0001
Age, y, %
<55 25.81 26.13 27.19 27.84 27.31 28.11 30.00 29.99 29.40 30.46 29.96 <0.0001
55 to 64 22.08 22.25 22.68 24.08 24.38 25.01 25.70 25.90 26.68 26.90 28.15 <0.0001
65 to 74 23.24 22.72 22.03 21.11 20.99 20.15 19.62 19.27 20.18 20.09 20.04 <0.0001
75 to 84 20.47 20.12 19.31 18.58 18.88 17.83 16.53 16.29 15.51 14.75 14.33 <0.0001
>84 8.40 8.78 8.79 8.39 8.44 8.90 8.15 8.55 8.23 7.80 7.51 <0.0001
Race, %
White 83.80 82.85 80.53 79.52 80.77 81.80 81.19 78.52 79.37 78.55 78.16 <0.0001
Black 6.16 6.32 6.87 7.28 6.99 5.56 6.51 7.78 7.06 7.21 8.07 <0.0001
Hispanic 5.55 6.05 6.91 7.85 6.64 7.42 7.04 7.37 6.28 6.85 7.36 <0.0001
Asian 1.69 1.53 2.06 2.20 2.22 1.78 1.95 2.08 2.23 2.20 2.37 <0.0001
AI/AN 0.26 0.37 0.22 0.18 0.30 0.27 0.43 0.57 0.99 0.64 0.93 <0.0001
Other 2.53 2.88 3.41 2.98 3.10 3.18 2.88 3.68 4.09 4.56 3.11 <0.0001
Comorbidities, %
T2DM 19.73 20.42 21.26 21.71 22.29 22.68 23.34 24.29 24.56 24.74 25.42 <0.0001
TIA/stroke 3.05 3.00 3.02 2.84 2.91 2.69 2.75 2.69 2.90 2.52 2.80 <0.0001
Heart failure 25.39 24.16 24.42 25.20 25.43 24.24 23.45 24.04 23.23 23.39 22.81 <0.0001
Prior MI 66.56 68.68 70.59 72.63 74.39 76.10 78.77 80.01 82.87 84.08 84.13 <0.0001
Hypertension 46.32 48.07 50.07 51.46 53.05 54.43 56.36 57.99 59.42 60.81 61.32 <0.0001
Renal failure 4.63 5.04 5.59 5.77 6.12 7.52 9.93 12.97 13.66 14.38 14.84 <0.0001
AFib 12.73 12.85 12.99 12.26 12.80 12.53 12.16 12.00 11.25 11.19 10.95 <0.0001
Dyslipidemia 30.38 33.50 37.68 39.52 43.26 46.92 49.91 53.47 55.06 57.06 58.82 <0.0001
PAD 2.94 2.98 3.27 3.29 3.31 3.25 3.41 3.67 3.87 3.65 3.66 <0.0001
Cancer 0.57 0.61 0.58 0.57 0.60 0.71 0.60 0.73 0.71 0.65 0.69 <0.0001
Dementia 0.64 0.63 0.52 0.51 0.44 0.51 0.48 0.40 0.38 0.39 0.29 <0.0001
Tobacco use 24.00 25.39 26.93 29.08 31.12 32.07 33.86 34.73 34.69 <0.0001
Obesity 11.4075 12.4402 12.5151 14.701 14.9526 15.7799 17.9707 19.4745 19.9242 <0.0001
In‐hospital, %
Shock 6.19 6.51 7.01 7.23 7.52 8.25 8.39 9.28 9.96 10.71 10.75 <0.001
VFib 4.27 4.23 4.61 4.59 4.85 4.88 5.11 5.46 5.72 6.16 6.19 <0.0001
Revasc 70.52 72.84 74.60 76.56 77.72 81.19 83.38 84.68 86.53 89.02 89.65 <0.0001
Mortality 9.09 8.57 8.36 7.93 7.77 7.65 6.85 7.14 6.93 6.63 6.32 <0.0001

AFib indicates atrial fibrillation; AI/NA, American Indian or Native American; MI, myocardial infarction; PAD, peripheral arterial disease; Revasc, coronary revascularization procedure; T2DM, type 2 diabetes mellitus; TIA, transient ischemic attack; VFib, ventricular fibrillation.